Tudor Investment Corp’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $297K | Sell |
12,916
-8,877
| -41% | -$204K | ﹤0.01% | 1388 |
|
2025
Q1 | $632K | Buy |
+21,793
| New | +$632K | ﹤0.01% | 1155 |
|
2024
Q4 | – | Sell |
-6,115
| Closed | -$297K | – | 1514 |
|
2024
Q3 | $297K | Sell |
6,115
-13,312
| -69% | -$646K | ﹤0.01% | 1347 |
|
2024
Q2 | $777K | Buy |
+19,427
| New | +$777K | ﹤0.01% | 1065 |
|
2024
Q1 | – | Sell |
-6,436
| Closed | -$398K | – | 1434 |
|
2023
Q4 | $398K | Sell |
6,436
-18,067
| -74% | -$1.12M | ﹤0.01% | 1191 |
|
2023
Q3 | $1.13M | Buy |
24,503
+396
| +2% | +$18.2K | 0.01% | 869 |
|
2023
Q2 | $1.39M | Buy |
24,107
+8,097
| +51% | +$465K | 0.02% | 778 |
|
2023
Q1 | $600K | Buy |
+16,010
| New | +$600K | 0.01% | 1082 |
|
2022
Q3 | – | Sell |
-30,676
| Closed | -$1.07M | – | 1561 |
|
2022
Q2 | $1.07M | Sell |
30,676
-9,719
| -24% | -$338K | 0.03% | 778 |
|
2022
Q1 | $1.45M | Sell |
40,395
-3,317
| -8% | -$119K | 0.03% | 679 |
|
2021
Q4 | $1.02M | Buy |
43,712
+253
| +0.6% | +$5.89K | 0.02% | 872 |
|
2021
Q3 | $826K | Buy |
43,459
+6,026
| +16% | +$115K | 0.01% | 945 |
|
2021
Q2 | $755K | Sell |
37,433
-6,356
| -15% | -$128K | 0.01% | 940 |
|
2021
Q1 | $802K | Buy |
43,789
+17,667
| +68% | +$324K | 0.02% | 935 |
|
2020
Q4 | $525K | Buy |
+26,122
| New | +$525K | 0.01% | 919 |
|
2017
Q2 | – | Sell |
-35,387
| Closed | -$513K | – | 1010 |
|
2017
Q1 | $513K | Buy |
35,387
+8,960
| +34% | +$130K | 0.02% | 664 |
|
2016
Q4 | $487K | Sell |
26,427
-316
| -1% | -$5.82K | 0.01% | 717 |
|
2016
Q3 | $507K | Sell |
26,743
-3,533
| -12% | -$67K | 0.01% | 708 |
|
2016
Q2 | $488K | Buy |
30,276
+9,887
| +48% | +$159K | 0.01% | 707 |
|
2016
Q1 | $245K | Buy |
+20,389
| New | +$245K | 0.01% | 1174 |
|